Pharmacodynamic evaluation of the protein kinase C (PKC) inhibitor CGP41251 (PKC412) in patients with metastatic melanoma.

M Millward; C House; L Webster; B Linahan; U Olver; G Toner; J Zalcberg; D Bowtell

Pharmacodynamic evaluation of the protein kinase C (PKC) inhibitor CGP41251 (PKC412) in patients with metastatic melanoma.

M Millward, C House, L Webster, B Linahan, U Olver, G Toner, J Zalcberg, D Bowtell

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

1 Citation (Web of Science)

Original language	English
Pages (from-to)	4549S-4549S
Number of pages	1
Journal	Clinical Cancer Research
Volume	6
Publication status	Published - Nov 2000
Externally published	Yes

Cite this

@article{80d846c7f65c45a59199138c81120b21,

title = "Pharmacodynamic evaluation of the protein kinase C (PKC) inhibitor CGP41251 (PKC412) in patients with metastatic melanoma.",

author = "M Millward and C House and L Webster and B Linahan and U Olver and G Toner and J Zalcberg and D Bowtell",

year = "2000",

month = nov,

language = "English",

volume = "6",

pages = "4549S--4549S",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

}

TY - JOUR

T1 - Pharmacodynamic evaluation of the protein kinase C (PKC) inhibitor CGP41251 (PKC412) in patients with metastatic melanoma.

AU - Millward, M

AU - House, C

AU - Webster, L

AU - Linahan, B

AU - Olver, U

AU - Toner, G

AU - Zalcberg, J

AU - Bowtell, D

PY - 2000/11

Y1 - 2000/11

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=uwapure5-25&SrcAuth=WosAPI&KeyUT=WOS:000165409000376&DestLinkType=FullRecord&DestApp=WOS

M3 - Abstract/Meeting Abstract

SN - 1078-0432

VL - 6

SP - 4549S-4549S

JO - Clinical Cancer Research

JF - Clinical Cancer Research

ER -

Pharmacodynamic evaluation of the protein kinase C (PKC) inhibitor CGP41251 (PKC412) in patients with metastatic melanoma.

Other files and links

Cite this